David Vranicar
President, Heartland BioVentures
Kansas Bioscience Authority

As president of Heartland BioVentures, David Vranicar leads commercialization programs and investments for the Kansas Bioscience Authority. Mr. Vranicar possesses a wide range of corporate development and operations expertise, having led merger and acquisition; strategic alliance; corporate finance; and information technology functions at companies in the healthcare, telecom, and software industries.

Mr. Vranicar led the development of the initial comprehensive financial plan for the University of Kansas Cancer Center and earlier worked at Marion Laboratories on numerous product licensing, joint marketing, and business development initiatives. He was a member of the founding management team at Birch Telecom, where he was involved in large rounds of equity financing and led the company’s IT and billing functions that supported growth to $300 million in revenue in six years. Mr. Vranicar also has held executive positions in business development and operations at several other high growth software companies.

Mr. Vranicar earned a bachelor’s degree from the University of Texas and a master’s degree in business from the University of Michigan.

“We are very excited about the collaboration that has taken place with the Kansas Bioscience Authority and are looking forward to bringing new job opportunities to the local community with this important investment in our business.”

- Tom Wilson, Vice President, Thermo Fisher   Scientific, Microbiology North America